Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5929)	11/12/1998 2:28:00 PM
From: scaram(o)uche	Respond to of 9719

>> Now, even though the model is milking this sucker, it does bum me out as I truly would love to see a cancer cure, but I'm just not convinced that this is it. << Rman: Just a quick comment..... the concept of using anti-angiogenesis for cancer is alive and well, and several rational approaches to the problem are advancing in trials. ENMD has been a curiosity. I really don't think that scientists at SUGN, IMCL, GNE, OSIP, REGN and the like ever feared ENMD as a serious competitor. But, even so, the severity of this statement really shocked me...... >> Says the company's (Bristol Myers) senior vice president of pharmaceutical development, Christopher Cimarusti: "There's a difference between a lab curiosity and something you can take forward in man." << Ugh. Rick